Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Detlef Bartkowiak

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Aktuelle Urologie|February 24, 2016
[Not Available]Detlef Bartkowiak
European Urology|October 2, 2014
PREFEREnce-based randomized evaluation of treatment modalities in low or early intermediate-risk prostate cancerThomas Wiegel, Michael Stöckle, Detlef Bartkowiak
Current Opinion in Urology|April 27, 2013
Adjuvant radiotherapy or early salvage radiotherapy in pT3R0 or pT3R1 prostate cancerDetlef Bartkowiak, Dirk Bottke, Thomas Wiegel
Future Oncology (London, England)|May 8, 2013
Radiotherapy in the management of prostate cancer after radical prostatectomyDetlef Bartkowiak, Dirk Bottke, Thomas Wiegel
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 17, 2009
Radiation- and chemoinduced multidrug resistance in colon carcinoma cellsDetlef Bartkowiak, Michael Stempfhuber, Thomas Wiegel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 13, 2002
The influence of bromodeoxyuridine on the induction and repair of DNA double-strand breaks in glioblastoma cellsNadine N Nusser, Detlef Bartkowiak, Erwin M Röttinger
European Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Salvage radiotherapy in patients with persisting/rising PSA after radical prostatectomy for prostate cancerDirk Bottke, Theo M de Reijke, Detlef Bartkowiak, et al.
BJU International|June 21, 2019
The impact of prostate-specific antigen persistence after radical prostatectomy on the efficacy of salvage radiotherapy in patients with primary N0 prostate cancerDetlef Bartkowiak, Alessandra Siegmann, Dirk Böhmer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 21, 2003
Enhanced renal toxicity of total body irradiation combined with radioimmunotherapyErwin M Röttinger, Detlef Bartkowiak, Donald Bunjes, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 8, 2007
A radioprotective effect of imatinib (Gleevec) in human squamous carcinoma cellsDetlef Bartkowiak, Peter R Hipp, Marc S Mendonca, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Aktuelle Urologie|February 24, 2016
[Not Available]Detlef Bartkowiak
European Urology|October 2, 2014
PREFEREnce-based randomized evaluation of treatment modalities in low or early intermediate-risk prostate cancerThomas Wiegel, Michael Stöckle, Detlef Bartkowiak
Current Opinion in Urology|April 27, 2013
Adjuvant radiotherapy or early salvage radiotherapy in pT3R0 or pT3R1 prostate cancerDetlef Bartkowiak, Dirk Bottke, Thomas Wiegel
Future Oncology (London, England)|May 8, 2013
Radiotherapy in the management of prostate cancer after radical prostatectomyDetlef Bartkowiak, Dirk Bottke, Thomas Wiegel
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 17, 2009
Radiation- and chemoinduced multidrug resistance in colon carcinoma cellsDetlef Bartkowiak, Michael Stempfhuber, Thomas Wiegel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 13, 2002
The influence of bromodeoxyuridine on the induction and repair of DNA double-strand breaks in glioblastoma cellsNadine N Nusser, Detlef Bartkowiak, Erwin M Röttinger
European Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Salvage radiotherapy in patients with persisting/rising PSA after radical prostatectomy for prostate cancerDirk Bottke, Theo M de Reijke, Detlef Bartkowiak, et al.
BJU International|June 21, 2019
The impact of prostate-specific antigen persistence after radical prostatectomy on the efficacy of salvage radiotherapy in patients with primary N0 prostate cancerDetlef Bartkowiak, Alessandra Siegmann, Dirk Böhmer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 21, 2003
Enhanced renal toxicity of total body irradiation combined with radioimmunotherapyErwin M Röttinger, Detlef Bartkowiak, Donald Bunjes, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 8, 2007
A radioprotective effect of imatinib (Gleevec) in human squamous carcinoma cellsDetlef Bartkowiak, Peter R Hipp, Marc S Mendonca, et al.
Pageof 4